Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States)

被引:94
|
作者
Ngo, TH
Barnard, RJ
Tymchuk, CN
Cohen, P
Aronson, WJ
机构
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
关键词
apoptosis; dietary fat; IGF-I axis; physical activity; prostate cancer;
D O I
10.1023/A:1021911517010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Accumulating evidence indicates that prostate cancer is associated with high levels of serum IGF-I. This study was conducted to determine whether a low-fat diet and exercise (DE) intervention may modulate the IGF axis and reduce prostate cancer cell growth in vitro. Methods: Fasting serum was obtained from 14 men (age 60 +/- 3 years) participating in an 11-day DE program and from eight similarly aged men who had followed the DE program for 14.2 +/- 1.7 years (long-term). Insulin, IGF-I, IGFBP-1, and IGFBP-3 were measured by ELISA, and serum was used to stimulate LNCaP cell growth in vitro. Results: Serum IGF-I levels decreased by 20% while IGFBP-1 increased by 53% after 11-day DE. In the long-term group, IGF-I was 55% lower, while IGFBP-1 was 150% higher relative to baseline. Serum insulin decreased by 25% after 11-day DE and was 68% lower in the long-term group, relative to baseline. No changes in serum IGFBP-3 were observed. Serum-stimulated LNCaP cell growth was reduced by 30% in post-11-day serum and by 44% in long-term serum relative to baseline. LNCaP cells incubated with post-DE serum showed increased apoptosis/necrosis, compared to baseline. Conclusions: A low-fat diet and exercise intervention induces in-vivo changes in the circulating IGF axis and is associated with reduced growth and enhanced apoptosis/necrosis of LNCaP tumor cells in vitro.
引用
收藏
页码:929 / 935
页数:7
相关论文
共 50 条
  • [21] Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3
    Lukanova, A
    Zeleniuch-Jacquotte, A
    Lundin, E
    Michel, A
    Arslan, AA
    Rinaldi, S
    Muti, P
    Lenner, P
    Koenig, KL
    Biessy, C
    Krogh, V
    Riboli, E
    Shore, RE
    Stattin, P
    Berrino, F
    Hallmans, C
    Toniolo, P
    Kaaks, R
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (02) : 262 - 268
  • [22] Circulating serum levels of IGF-I, IGFBP-1, IGFBP-3 and VEGF in diabetic patients with retinopathy and healthy control subjects.
    Luettke, B
    Lang, GE
    Lang, GK
    Boehm, BO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3233 - 3233
  • [23] Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
    Harrela, M
    Koistinen, H
    Kaprio, J
    Lehtovirta, M
    Tuomilehto, J
    Eriksson, J
    Tolvanen, L
    Koskenvuo, M
    Leinonen, P
    Koistinen, R
    Seppala, M
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11): : 2612 - 2615
  • [24] EFFECT OF INSULIN ON THE HEPATIC PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 (IGFBP-1), IGFBP-3, AND IGF-I IN INSULIN-DEPENDENT DIABETES
    BRISMAR, K
    FERNQVISTFORBES, E
    WAHREN, J
    HALL, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03): : 872 - 878
  • [25] IN-VIVO ACTIONS OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ON BRAIN MYELINATION - STUDIES OF IGF-I AND IGF BINDING PROTEIN-1 (IGFBP-1) TRANSGENIC MICE
    YE, P
    CARSON, J
    DERCOLE, AJ
    JOURNAL OF NEUROSCIENCE, 1995, 15 (11): : 7344 - 7356
  • [26] Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells
    Poretsky, L
    Chandrasekher, YA
    Bai, C
    Liu, HC
    Rosenwaks, Z
    Giudice, L
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02): : 493 - 496
  • [27] Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density
    Cornelia W. Taverne
    Martijn Verheus
    James D. McKay
    Rudolf Kaaks
    Federico Canzian
    Diederick E. Grobbee
    Petra H. M. Peeters
    Carla H. van Gils
    Breast Cancer Research and Treatment, 2010, 123 : 843 - 855
  • [28] Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density
    Taverne, Cornelia W.
    Verheus, Martijn
    McKay, James D.
    Kaaks, Rudolf
    Canzian, Federico
    Grobbee, Diederick E.
    Peeters, Petra H. M.
    van Gils, Carla H.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 843 - 855
  • [29] IGF-I, IGF-II, free IGF-I and IGFBP-1, IGFBP-2 and IGFBP-3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns
    Klauwer, D
    Blum, WF
    Hanitsch, S
    Rascher, W
    Lee, PDK
    Kiess, W
    ACTA PAEDIATRICA, 1997, 86 (08) : 826 - 833
  • [30] Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction
    Koutsaki, Maria
    Sifakis, Stavros
    Zaravinos, Apostolos
    Koutroulakis, Dimitrios
    Koukoura, Ourania
    Spandidos, Demetrios A.
    GROWTH HORMONE & IGF RESEARCH, 2011, 21 (01) : 31 - 36